Lupin Digital Health CEO Sidharth Srinivasan Explores the Transformative Impact of Digital Therapeutics
India Live 2024 , the paramount global cardiology event hosted by the Interventional Cardiology Foundation of India, focused on Interventional Cardiology: enabling quality outcomes for heart disease patients.
Amidst this backdrop, Lupin Digital Health and the American College of Cardiology (ACC) announced a pioneering collaboration to introduce Digital Therapeutics (DTx) in India, aimed at delivering in-home cardiovascular care.
Their flagship product, Lyfe, launched just a year ago, represents a groundbreaking digital therapeutic solution designed to monitor and manage acute coronary syndrome (ACS) patients using advanced technologies.
In our conversation, with Mr. Sidharth Srinivasan, CEO of Lupin Digital Health, share insights on the transformative power of digital therapeutics. He discussed how Lupin Digital Health revolutionized healthcare in India by leveraging DTx and Remote Patient Monitoring to improve outcomes and reduce rehospitalization rates and explored the potential and challenges of digital therapeutics in reshaping cardiac care in India.
Facebook Comments
